OUTLOOK THERAPEUTICS INC

NASDAQ: OTLK
$8.50
-$0.10 (-1.2%)
Closing price May 6, 2024

OTLK Chart and Intraday Price

OTLK Company Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 7 CLARKE DRIVE, CRANBURY, NJ, US
Fiscal Year End September
Latest Quarter 2023-12-31
Market Cap 205.48M USD
Shares Outstanding 21,584,300
Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company is headquartered in Cranbury, New Jersey.

OTLK Articles

A quiet week so far with markets trading slightly higher and analyst ratings trickling in. Just enough action to keep investors interested.